Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions
Abstract Patients with underlying health conditions are vulnerable to invasive fungal infection following COVID‐19. It seems that uncontrolled diabetes mellitus makes patients susceptible to both severe COVID‐19 and mucormycosis.
Guardado en:
Autores principales: | Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei‐Jandaghi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb800dc93e534d55922e65f5b9af7166 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021) -
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
por: Helena Codina, et al.
Publicado: (2021) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Junyan Qu, et al.
Publicado: (2021) -
COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
por: Abiu Sempere, et al.
Publicado: (2021) -
A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19
por: Johanna Reinold, et al.
Publicado: (2021)